Amedeo Smart

Free Medical Literature Service


 

Amedeo

HIV Infection

  Free Subscription

21.09.2026

4 AIDS
1 Ann Intern Med
1 BMJ
1 Cell
2 Clin Infect Dis
3 HIV Med
2 J Acquir Immune Defic Syndr
1 J Infect Dis
1 Lancet
1 N Engl J Med
1 Nat Med
1 PLoS Med
7 PLoS One
2 Vaccine
1 Virology



    AIDS

  1. FILIP I
    Can low-burden HIV pre-exposure prophylaxis become affordable in low- and middle-income countries?
    AIDS. 2026 Sep 18. doi: 10.1097/QAD.0000000000004626.
    >> Share

  2. LUJINTANON S, Rebeiro PF, Althoff KN, Jones JL, et al
    Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?
    AIDS. 2026 Sep 18. doi: 10.1097/QAD.0000000000004623.
    >> Share

  3. ZHAO S, McCallum S, Awwad A, Castle PE, et al
    Cancer incidence and risk factors among people with HIV in REPRIEVE.
    AIDS. 2026 Sep 18. doi: 10.1097/QAD.0000000000004625.
    >> Share

  4. DAHER J, Koberssy Z, Moussallem N, Wu Q, et al
    Effects of semaglutide on subclinical cardiovascular health in people with HIV.
    AIDS. 2026 Sep 17. doi: 10.1097/QAD.0000000000004624.
    >> Share


    Ann Intern Med

  5. ARNOLD MJ, Spacek L, Bush KNV, Waring AA, et al
    A Synopsis of the 2025 U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline for Lipid Management for Cardiovascular Disease Risk Reduction.
    Ann Intern Med. 2026 Sep 15. doi: 10.7326/ANNALS-26-01374.
    >> Share


    BMJ

  6. STOICESCU C, Mohd Salleh NA, Giacomello C, Faye RAY, et al
    The war on drugs is a war on women.
    BMJ. 2026;394:e100686.
    >> Share


    Cell

  7. XAVIER A, Kolling M, Bourke AM, Mosler T, et al
    Programmed ribosomal frameshifting triggers translational stress to promote viral replication.
    Cell. 2026 Sep 14:S0092-8674(26)01004-4. doi: 10.1016/j.cell.2026.
    >> Share


    Clin Infect Dis

  8. CLARK DC, Banerjee J, Baden R, Coffey C, et al
    Health Economic Analysis of the AMBITION Protocol for Human Immunodeficiency Virus-Associated Cryptococcal Meningitis in the United States.
    Clin Infect Dis. 2026 Sep 17:ciag485. doi: 10.1093.
    >> Share

  9. LAWRENCE DS, Jarvis JN
    When the Evidence Aligns: Single-Dose Liposomal Amphotericin B for Cryptococcal Meningitis in High-Income Settings.
    Clin Infect Dis. 2026 Sep 17:ciag487. doi: 10.1093.
    >> Share


    HIV Med

  10. LIU Q, Luo Y, Shan Q, Zhu D, et al
    Association of delayed ART initiation with mortality according to documented concurrent clinical conditions in adults with HIV: A multicentre cohort study.
    HIV Med. 2026 Sep 13. doi: 10.1111/hiv.70307.
    >> Share

  11. PIACENTINI D, Cosimi L, Castagna A, Cattelan A, et al
    Clinical management of pregnancy, delivery and breastfeeding in women living with HIV in Italy: A survey of participating infectious diseases centres.
    HIV Med. 2026 Sep 14. doi: 10.1111/hiv.70308.
    >> Share

  12. BRANAS F, Galindo MJ, Torralba M, Antela A, et al
    Quality of life among older adults with HIV after switching to bictegravir-based three-drug or dolutegravir-based two-drug regimens.
    HIV Med. 2026 Sep 17. doi: 10.1111/hiv.70310.
    >> Share


    J Acquir Immune Defic Syndr

  13. LUCAS A, Steiner L, Genade L, Pattamukkil A, et al
    Trends in Tuberculosis Preventive Therapy Prescribing Among People Living with HIV in South Africa, 2005-2022.
    J Acquir Immune Defic Syndr. 2026 Sep 17. doi: 10.1097/QAI.0000000000003976.
    >> Share

  14. FERRARIS CM, D'Avanzo PA, Schiavoni NF, Knox J, et al
    Longitudinal Performance of Self-Reported ART Adherence Compared With Tenofovir Diphosphate in Dried Blood Spots in South Africa.
    J Acquir Immune Defic Syndr. 2026 Sep 16. doi: 10.1097/QAI.0000000000003975.
    >> Share


    J Infect Dis

  15. MULLER JG, Ngasala BE, Sanders EA, Yang G, et al
    Parasite strain turnover and mosquito infectivity in untreated subpatent malaria.
    J Infect Dis. 2026 Sep 15:jiag463. doi: 10.1093.
    >> Share


    Lancet

  16. BWAKURA-DANGAREMBIZI M, Chappell E, Kityo C, Anena DL, et al
    Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.
    Lancet. 2026 Sep 17:S0140-6736(26)01537-0. doi: 10.1016/S0140-6736(26)01537.
    >> Share


    N Engl J Med

  17. MGBAKO O
    Honoring the Legacy of the HIV Epidemic.
    N Engl J Med. 2026;395:1048-1049.
    >> Share


    Nat Med

  18. FUMAGALLI MJ, Kaczynska A, Allombert M, Lopes-Ribeiro A, et al
    Broadly neutralizing antibodies in adult males living with HIV undergoing analytical treatment interruption: secondary and exploratory outcomes of the phase II randomized controlled RIO trial.
    Nat Med. 2026 Sep 15. doi: 10.1038/s41591-026-04644.
    >> Share


    PLoS Med

  19. GRANICH R, Gupta S, Munyangaju I, Ruffner M, et al
    HIV self-testing and the global diagnostic gap: Addressing a decade of missed opportunity.
    PLoS Med. 2026;23:e1005241.
    >> Share


    PLoS One

  20. VREEMAN R, Nyandiko W, DeLong A, Chory A, et al
    Adherence to antiretroviral therapy and drug resistance impact evolving viral suppression among a cohort of children and adolescents living with perinatal HIV infection in western Kenya.
    PLoS One. 2026;21:e0355492.
    >> Share

  21. ASSELE DD, Mohammed YE, Ganta AG, Darebo TD, et al
    The effect of antiretroviral therapy adherence on viral load suppression rate among people living with HIV in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2026;21:e0358352.
    >> Share

  22. NAKAGAWA F, Delpech V, Smith CJ, Pelchen-Matthews A, et al
    Sociodemographic variations in healthcare service use among people with HIV in the UK.
    PLoS One. 2026;21:e0354425.
    >> Share

  23. MUSYOKI VM, Mureithi M, Heikinheimo A, Maleche-Obimbo E, et al
    Temporal patterns of tuberculosis-associated hyperglycaemia and its effect on treatment outcomes in individuals not previously diabetic: A prospective cohort study.
    PLoS One. 2026;21:e0358593.
    >> Share

  24. KUATE MPN, Ramkumar K, Dalmieda J, Nadeem J, et al
    Genetic diversity and antifungal susceptibility among ecological niche populations of Aspergillus flavus in Yaounde, Cameroon.
    PLoS One. 2026;21:e0355362.
    >> Share

  25. GWANZURA TNR, Trepka MJ, Li T, Juhasz L, et al
    COVID-19 mortality risk among people with HIV in Florida before and after the introduction of COVID-19 vaccines: A population-based study.
    PLoS One. 2026;21:e0358543.
    >> Share

  26. SU E, Sirisegaram L, Singh H, Eaton AD, et al
    The role of co-design and co-creation methodologies in research supporting older adults living with HIV: A scoping review.
    PLoS One. 2026;21:e0358263.
    >> Share


    Vaccine

  27. SBARRA AN, Mutembo S, Carcelen A, Prosperi C, et al
    Multi-pathogen serosurveillance reveals correlated vaccination performance, waning tetanus immunity, and diphtheria boosting in Zambian children.
    Vaccine. 2026;92:129160.
    >> Share

  28. LAOHARATTANAHIRUN N, Kiertiburanakul S, Boonnak K, Bruminhent J, et al
    Immunogenicity and safety of high-dose versus standard-dose quadrivalent inactivated influenza vaccine in patients living with HIV: a randomized controlled trial.
    Vaccine. 2026;92:129166.
    >> Share


    Virology

  29. CHAPHEKAR D, Rajakumar RC, Persaud AT, Fernandes C, et al
    Applying intravirion staining to discern extracellular vesicles from viruses with flow virometry.
    Virology. 2026;625:111081.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016